ImmPACT Bio USA: Funding, Investors & Team (Sep 2026)
ImmPACT Bio USA Inc. is a cell therapy company aiming to develop potent and selective engineered T-cells for the treatment of solid tumors. The Company's technology enables targeting loss-of-gene features of solid tumor cells, sparing normal, healthy tissues.
ImmPACT Bio USA has raised $18.0M across 1 funding round on record, the most recent an undisclosed round of $18.0M announced in Aug 2020.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ImmPACT Bio USA Company Profile and Key Stats
Latest funding round on record: Aug 2020.
ImmPACT Bio USA Funding Rounds
ImmPACT Bio USA Founders and Leadership Team
No contact details are on record for this team yet.
ImmPACT Bio USA Funding Compared to Other Biotechnology Startups
ImmPACT Bio USA's latest round of $18.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ImmPACT Bio USA in Biotechnology and Camarillo
Companies Similar to ImmPACT Bio USA
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
ImmPACT Bio USA Funding FAQs
What does ImmPACT Bio USA do?
ImmPACT Bio USA Inc. is a cell therapy company aiming to develop potent and selective engineered T-cells for the treatment of solid tumors. The Company's technology enables targeting loss-of-gene features of solid tumor cells, sparing normal, healthy tissues.
How much funding has ImmPACT Bio USA raised?
ImmPACT Bio USA has raised $18.0M across 1 round on record. The most recent is an undisclosed round of $18.0M announced in Aug 2020.
When did ImmPACT Bio USA last raise funding?
ImmPACT Bio USA's most recent funding round on record is an undisclosed round of $18.0M, announced in Aug 2020.
Who is the CEO of ImmPACT Bio USA?
Rick Kendall is listed as CEO at ImmPACT Bio USA.
Where is ImmPACT Bio USA headquartered?
ImmPACT Bio USA is based in Camarillo, California, United States.
How many employees does ImmPACT Bio USA have?
ImmPACT Bio USA is in the 1-10 employee band.
How does ImmPACT Bio USA's funding compare to other Biotechnology startups?
ImmPACT Bio USA's latest round of $18.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's ImmPACT Bio USA Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ImmPACT Bio USA is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.